Filing Flows › Innoviva (INVA) › Product revenue
Innoviva (INVA) Product revenue by quarter
Innoviva's Product revenue was $49.4M in Q3 2026 (third quarter 2026), -4% from Q2 2026. Over the last 7 quarters it ranged from $30.3M (Q1 2025) to $58.9M (Q4 2025).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $49.4M | -4% | +5% |
| Q2 2026 | $51.8M | +25% | +46% |
| Q1 2026 | $41.4M | -30% | +37% |
| Q4 2025 | $58.9M | +25% | — |
| Q3 2025 | $47.2M | +33% | — |
| Q2 2025 | $35.5M | +17% | — |
| Q1 2025 | $30.3M | — | — |
Q3 2026 at a glance
Innoviva, Q3 2026: revenue $106M (-2% year over year), operating margin 39.7%, net loss $73.9M, operating cash flow $41.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Innoviva's Product revenue?
Innoviva's Product revenue was $49.4M in Q3 2026 (third quarter 2026), -4% from Q2 2026.
How has Innoviva's Product revenue changed?
Over the last 7 quarters it ranged from $30.3M (Q1 2025) to $58.9M (Q4 2025).